Kyowa Kirin Co., Ltd. and Kura Oncology, Inc. have initiated a **Phase 2 registrational clinical trial** (jRCT2031250550) for **ziftomenib**, an oral menin inhi...
Dogecoin Cash, Inc. (OTCQB: DOGP) is strategically leveraging its majority ownership of PrestoDoctor to enhance its telehealth platform in light of recent feder...
A recent cross-sectional study has revealed significant correlations between **gut microbiome (GM) composition** and physical activity levels in older adults, c...
**Dasatinib and Quercetin (DQ) demonstrate superior efficacy over Navitoclax in mitigating intervertebral disc degeneration in a senescence-driven mouse model.*...
Amphista Therapeutics has unveiled promising pre-clinical data on their **SMARCA2** and **TEAD Targeted Glue™** programs at the AACR Annual Meeting, highlightin...
Levicept Ltd has unveiled promising data from its Phase II clinical trial of **LEVI-04**, a novel **neurotrophin-3 inhibitor** targeting osteoarthritis (OA) pai...
The **tissue engineering market** is poised for significant growth, projected to expand from **USD 15.01 billion in 2026 to USD 27.59 billion by 2031**, with a...
Alterity's recent presentation at the American Academy of Neurology annual meeting highlighted promising results from the ATH434-201 Phase 2 trial in Multiple S...
Rafael Holdings, Inc. has secured an exclusive licensing agreement with the Massachusetts Institute of Technology for U.S. Patent No. 12285440, which pertains t...
4Moving Biotech has received **Fast Track Designation** from the U.S. FDA for its investigational drug **4P004**, aimed at treating knee osteoarthritis in patie...
Antag Therapeutics is set to unveil pivotal clinical and preclinical data on **AT7687**, a first-in-class **GIP receptor antagonist peptide**, during the upcomi...
Springfield Wellness Center has marked a significant milestone by celebrating its 25th anniversary as a pioneering clinic in intravenous **NAD+ treatment** for...
The FDA has approved **Otarmeni (lunsotogene parvec-cwha)**, marking a significant advancement as the first dual adeno-associated virus (AAV) vector-based gene...
A recent study led by Rays H. Y. Jiang from the University of South Florida has confirmed the existence of a **mass grave** from the Plague of Justinian in anci...
Trevi Therapeutics, Inc. has announced significant advancements regarding its investigational therapy, **Haduvio™** (oral nalbuphine ER), aimed at treating chro...
The ROOT Brands has been awarded the **Gold Stevie® Award** for Patent-Driven Wellness Innovation in the 2026 American Business Awards®, recognizing its commitm...
Regeneron Pharmaceuticals has announced a groundbreaking initiative to provide its recently approved gene therapy, **Otarmeni™ (lunsotogene parvec-cwha)**, at n...
The Oxford Treatment Center in Etta, Mississippi, reports a **35% increase** in alcohol-related admissions over the past year, highlighting a troubling trend in...
On April 23, Cook County Health marked the **60th anniversary** of its Trauma & Burn Department at John H. Stroger, Jr. Hospital, a pioneering unit established...
Artificial intelligence (AI) is revolutionizing the **nerve monitoring systems** landscape, as highlighted in BCC Research's latest analysis. The report undersc...
Chronic Kidney Disease (CKD) has been increasingly recognized as a condition that may represent **accelerated kidney aging**, with cellular senescence playing a...
Grace Therapeutics, Inc. has received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for **GTx-104**, a novel injectable...
ŌURA is strategically evolving from a consumer-facing wearable device into a comprehensive health infrastructure platform through a series of acquisitions, the...